8/22/2019

Dicyclomine Injection

Reason for the Shortage

- Allergan has Bentyl injection available.
- Akorn has dicyclomine injection for intramuscular use available.
- American Regent did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Nexus has dicyclomine injection for intramuscular use available.

Available Products

- Bentyl intramuscular solution for injection, Allergan, 10 mg/mL, 2 mL ampule, 5 count, NDC 58914-0080-52
- Dicyclomine hydrochloride intramuscular solution for injection, Akorn, 10 mg/mL, 2 mL single dose vial, 5 count, NDC 17478-0015-02
- Dicyclomine hydrochloride intramuscular solution for injection, American Regent, 10 mg/mL, 2 mL single dose vial, 5 count, NDC 00517-1980-05
- Dicyclomine hydrochloride intramuscular solution for injection, Hikma, 10 mg/mL, 2 mL single dose vial, 10 count, NDC 00641-6173-10
- Dicyclomine hydrochloride intramuscular solution for injection, Nexus Pharmaceuticals, 10 mg/mL, 2 mL single dose vial, 5 count, NDC 14789-0010-02

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated August 22, 2019 by Megan Dryer, PharmD. Created January 16, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.